In addition, puerarin markedly rescued cognitive deficits and reduced phosphorylation levels at the Thr231, Ser396, and Ser 195/198/199/202 sites of tau via the inhibition of glycogen synthase kinase-3β (GSK-3β) in several AD animal models [22-24]. Here, MAPT is linked to Alzheimer disease.